Barfani Baba Pharma Private Limited
About Barfani Baba Pharma Private Limited
Data last updated:
Barfani Baba Pharma Private Limited was a private limited company based in New Delhi, Delhi, India, operated as a subsidiary of Manvin Health Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 July 2009.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U52602DL2009PTC192681.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.2 Lakh. It was led by directors Radhika Pruthi and Meera Pruthi.
Its last annual general meeting (AGM) was held on 29 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at M – 134 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.54 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.42 Cr (net margin 92.3%) and EBITDA of ₹1.54 Cr (EBITDA margin 99.9%).
As per MCA filings, the company had satisfied charges of ₹15.5 Cr on record.
Company details
Contact details
Barfani Baba Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressM – 134 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Barfani Baba Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Barfani Baba Pharma Private Limited
FY 2020 filings availableBarfani Baba Pharma Private Limited reported revenue of ₹1.54 Cr (up 1825% YoY) for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.54 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.9% | ||||
| Net Profit Margin | 92.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Barfani Baba Pharma Private Limited, buy the company report.
Board of directors of Barfani Baba Pharma Private Limited
Barfani Baba Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Radhika Pruthi | Director | 24 Sep 2014 | 12 Years 1 Months | As last reported |
| Meera Pruthi Also directs: Aaloha Lifesciences Private Limited, Vinman Health Private Limited, Quad Lifesciences Private Limited and 2 more | Director | 20 Jan 2020 | 6 Years 9 Months | As last reported |
Peer comparison
Barfani Baba Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inowell Pharma Private Limited | ₹1.55 Cr (FY 2025) | 33.0% | Indore, Madhya Pradesh, India | |||
| Swasthsampada Health Care Private Limited | ₹1.55 Cr (FY 2025) | 380.0% | Mirzapursadar, Uttar Pradesh, India | |||
| Bigwig Remedies Private Limited | ₹1.55 Cr (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Bestead Lifesciences Private Limited | ₹1.54 Cr (FY 2025) | 1.0% | Delhi, India | |||
| Ace Remedies Private Limited | ₹1.54 Cr (FY 2025) | 21.0% | Pune, Maharashtra, India | |||
| Barfani Baba Pharma Private Limitedthis company | ₹1.54 Cr (FY 2020) | ₹1.42 Cr | 92.3% | 1825.0% | New Delhi, Delhi, India | |
| Vetrx Formulations Private Limited | ₹1.54 Cr (FY 2025) | -12.0% | Kanpur, Uttar Pradesh, India | |||
| Chaudhary Distributors Private Limited | ₹1.54 Cr (FY 2025) | 69.0% | Indore, Madhya Pradesh, India | |||
| Effibar India Private Limited | ₹1.54 Cr (FY 2024) | -64.0% | Delhi, India | |||
| Nexzen Formulations Limited | ₹1.54 Cr (FY 2025) | -11.0% | Chennai, Tamil Nadu, India | |||
| Articon Labs Private Limited | ₹1.54 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Barfani Baba Pharma Private Limited, buy the company report.
Auditor
Barfani Baba Pharma Private Limited is audited by S K D & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K D & ASSOCIATES | FY 2020 | 023842N |
Shareholding
The shareholding of Barfani Baba Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Barfani Baba Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2015 | 10611717 | Canara Bank | ₹50 Lakh | Satisfied | |
| 18 Sep 2013 | 10453062 | Others | ₹15 Cr | Satisfied |
To see the full charge records of Barfani Baba Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Barfani Baba Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Barfani Baba Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Barfani Baba Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Barfani Baba Pharma Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Meera Pruthi ceased to be Additional Director on 29 Dec 2020.
4 earlier events are in the company report.
Frequently asked questions
Barfani Baba Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Barfani Baba Pharma was a private limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 July 2009 and is registered under CIN U52602DL2009PTC192681. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Barfani Baba Pharma was incorporated on 29 July 2009. It is registered with the Registrar of Companies, Delhi.
Barfani Baba Pharma had 2 directors:
- Radhika Pruthi - Director
- Meera Pruthi - Director
The CIN (Corporate Identification Number) of Barfani Baba Pharma is U52602DL2009PTC192681. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Barfani Baba Pharma is at M – 134 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001.
The latest financial statements of Barfani Baba Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 29 December 2020. Year-wise statements from 2015 are in the company report.
Barfani Baba Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Barfani Baba Pharma by revenue are Inowell Pharma Private Limited, Swasthsampada Health Care Private Limited, Bigwig Remedies Private Limited, Bestead Lifesciences Private Limited, Ace Remedies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Meera Pruthi ceased to be Additional Director on 29 Dec 2020. Meera Pruthi was appointed as Director on 20 Jan 2020. Sushma Pruthi ceased to be Director on 20 Jan 2020. Barfani Baba Pharma has 8 board changes on record in total.
Barfani Baba Pharma has no open charges and satisfied charges of ₹15.5 Cr as per latest MCA filings.